After GDF-15 treatment (100 μg/kg), CD8+, CD11b+, CD19+, CD11C+, and TH2 cells were significantly decreased compared to those in pristane-induced lupus mice, and this was the most efficient compared to what other does (Figures 5A–D). Here, ITGAX is linked to systemic lupus erythematosus.